STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

Coverage, in order

1. 2d ago
   
   first STAT News indie

   STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

   The Food and Drug Administration on Monday approved Bayer’s drug to reduce recurrence of stroke, making available the first in a novel class of medications that hold the promise of preventing blood clots more safely. Many blood thinners aren’t used in this setting due to their increased risk of…

2. 1d ago
   Life Science Sweden Sweden indie

   FDA approves Bayer’s first-in-class stroke drug
3. 1d ago
   Pharmaphorum UK indie

   Bayer bags FDA green light for stroke drug Sunharbo

   Bayer bags FDA green light for stroke drug Sunharbo Phil.Taylor Tue, 10/11/2026 - 09:36

4. 1d ago
   
   MedCity News indie study

   FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke

   Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.